| Literature DB >> 33490984 |
Sydney J Reitz1, Andrew D Sauerbeck1, Terrance T Kummer1.
Abstract
Synapses are crucial to brain function and frequent disease targets, but current analysis methods cannot report on individual synaptic components in situ or present barriers to widespread adoption. SEQUIN was developed to address this challenge. SEQUIN utilizes a widely available super-resolution platform in tandem with image processing and analysis to quantify synaptic loci over large regions of brain and characterize their molecular and nanostructural properties at the individual and population level. This protocol describes quantification of synaptic loci using SEQUIN. For additional details on the use and execution of this protocol, please refer to Sauerbeck et al. (2020).Entities:
Keywords: Microscopy; Neuroscience
Mesh:
Year: 2021 PMID: 33490984 PMCID: PMC7811167 DOI: 10.1016/j.xpro.2020.100268
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1SEQUIN workflow
Overview of the SEQUIN data analysis workflow. Software associated with each step is listed in blue. Figure adapted with permission from Sauerbeck et al. (2020).
Figure 2Image pre-processing
(A) Single detector (central detector) image prior to Airyscan processing (above) and the Airyscan processed result (below).
(B) Channel alignment image shown with orthogonal views before (upper left) and after (lower left) adjustment. Panels to right depict process for determining and correcting chromatic aberration in Z, involving a temporary transposition in Y.
Figure 3Puncta detection in tissue
Three-dimensional image taken in mouse cortex labeled with PSD-95 and Synapsin. Panels to right show puncta detection and rendering using Imaris, with appropriate filtering applied to remove puncta at the edges of the image.
Figure 4Synaptic quantification strategy
Bimodal histogram indicating both the first and second peaks. Dashed line marks cutoff point, and shaded region indicates area to sum for synaptic quantification (NOTE: other quantification options may be used; see text and Figure 5).
Figure 5Additional synaptic quantification strategies
(A) Standard frequency distribution, overlaid with flipped distribution and flipped subtracted distribution.
(B) Gaussian curves fitted to the first and second peak of a standard frequency distribution.
Figure 6Minimal-to-no synapse peak
Frequency distribution with little-to-no synapse peak.
List of immunolabeling and imaging controls
| Necessary controls | Function | Antibodies |
|---|---|---|
| No anti-PSD-95 | to ensure secondary antibody specificity and lack of spectral cross-talk | 10: Gp anti-Synapsin 1/2 OR Ms anti-Synapsin 1 |
| No anti-synapsin | 10: Rb anti-PSD-95 | |
| Channel alignment | to measure and correct chromatic aberration post-acquisition | 10: Rb anti-PSD-95 |
| Previously validated tissue | to differentiate tissue preparation from immunolabeling problems | 10: Rb anti-PSD-95, Gp anti-Synapsin 1/2 OR Ms anti-Synapsin 1 |
| Previously validated slide | to validate imaging and analysis workflow |
Rb, rabbit; PSD, postsynaptic density; Gt, goat; Gp, guinea pig; Ms, mouse.
Previously validated tissue is tissue that has previously been labeled, imaged, and analyzed and has yielded quantifiable results.
Previously validated slide is tissue that was previously labeled, imaged, and analyzed (using the same antibody combinations as the current experimental tissue) and yielded quantifiable results.
Figure 7Left shifted frequency distribution
Left shifted frequency distribution with minimal secondary peak, often indicative of antibody or fluorophore cross-talk.
Figure 8XY shift
An excerpt from an orthogonal view of an image from an imaging session in which the stage shifted during imaging (bottom panel) compared to an image from a session with minimal shift (top panel).
Figure 9Fluorescence intensity variation through Z
An image with varying fluorescence intensity through Z (bottom) compared to an image with stable fluorescence intensity (top).
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Rabbit anti-PSD-95 (1:200) | Invitrogen | Cat# 51-6900, RRID: |
| Guinea pig anti-Synapsin 1/2 (1:500) | Synaptic Systems | Cat# 106004, RRID: |
| Mouse anti-Synapsin 1 (1:200) | Invitrogen | Cat# MA5-31919, RRID: |
| Goat anti-rabbit IgG-Alexa 594+ (1:200) | Invitrogen | Cat# A32740, RRID: |
| Goat anti-rabbit Alexa 488 (1:200) | Invitrogen | Cat# A11034, RRID: |
| Goat anti-guinea pig IgG-Alexa 488 (1:200) | Invitrogen | Cat# A11073, RRID: |
| Goat anti-mouse IgG-Alexa 488+ (1:200) | Invitrogen | Cat# A32723, RRID: |
| 10× phosphate buffered saline | Corning | Cat# 46-013-CM |
| Normal goat serum | Vector | Cat# S-1000, RRID: |
| Mowiol 488 | Electron Microscopy Services | Cat# 17977-150 |
| Antifade 300 | Electron Microscopy Services | Cat# 17977-25 |
| 1.5 H coverglass | Marienfeld | Cat# 0107242 |
| Mouse: C57/BL6J | The Jackson Laboratory | Cat# 000664 |
| Zen Digital Imaging for Light Microscopy | Zeiss | RRID:SCR_013672 |
| Imaris | Bitplane | RRID:SCR_007370 |
| Python | Python Software Foundation | RRID:SCR_008394 |
| MATLAB | MathWorks | RRID:SCR_001622 |
| SEQUIN MATLAB Code | This report | |
| Zeiss LSM 880 Fast Airyscan | Zeiss | N/A |
| Z-Piezo | Zeiss | N/A |
| 63× oil objective | Zeiss | Cat# 420782-9900-000 |